Open-Label Extension Of Intravenous Mepolizumab In Patients With Hypereosinophilic Syndrome
Clinical trial NCT00097370 · TERMINATED
Trial details
- NCT number
- NCT00097370
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-09-30
- Primary completion
- 2010-09-29
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.